ID
17933
Beschrijving
A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00201825
Link
https://clinicaltrials.gov/show/NCT00201825
Trefwoorden
Versies (1)
- 10-10-16 10-10-16 -
Geüploaded op
10 oktober 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lung Cancer NCT00201825
Eligibility Lung Cancer NCT00201825
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
Mental disorders Interfere with Informed Consent | Mental disorders Interfere with Follow-up
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0004936
- UMLS CUI [1,2]
- C0521102
- UMLS CUI [1,3]
- C0021430
- UMLS CUI [2,1]
- C0004936
- UMLS CUI [2,2]
- C0521102
- UMLS CUI [2,3]
- C3274571
Beschrijving
Diabetic - poor control | Random blood glucose level result
Datatype
boolean
Alias
- UMLS CUI [1]
- C0421258
- UMLS CUI [2]
- C1261429
Similar models
Eligibility Lung Cancer NCT00201825
- StudyEvent: Eligibility
C0205179 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0521102 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C3274571 (UMLS CUI [2,3])
C1261429 (UMLS CUI [2])